First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant

Konference: 2011 53rd ASH Annual Meeting – účast ČR

Kategorie: Chemoterapie; Maligní lymfomy a leukémie

Téma: 731. Clinical Allogeneic and Autologous Transplantation - Results: Poster III

Číslo abstraktu: 4110

Autoři: MD Francesco Annibale d'Amore, SMSci; M.D. Maria Gomes da Silva, Ph.D.; prof. Sirpa Leppä; Thomas Relander; Antonio Pezzutto; Grete Fossum Lauritzsen; Eckhart Weidmann; Michel Van Gelder; Mats Merup; Hans Hagberg; Unn-Merete Fagerli; Peter de Nully Brown; Per Boye Hansen; Jose Mario Mariz; MUDr. Milada Jankovská; MD Jan Andrzej Walewski, Ph.D.; MD Jeanette K Doorduijn, PhD; Achiel Van Hoof; Ilse Christiansen; Sirkku Jyrkkiö; Johanna C. Kluin-Nelemans; Marinus van Marwijk Kooy; Rob Fijnheer; Wendy Stevens; Jose Zijlstra, MD; L. Böhmer; Pieternella J. Lugtenburg; Matthias Grube; MUDr. Vít Procházka, Ph.D.; MUDr. David Šálek, Ph.D.; MD Richard Greil, Ph.D.; Lorenz Trümper; Gerald Wulf; Bettina Altmann; Marita Ziepert; Markus Loeffler; Esa Jantunen; Georg Hopfinger; M.D. Eric Van den Neste, Ph.D.; Helle Toldbod

Datum přednesení příspěvku: 12. 12. 2011